MU JHU CARE LIMITED
Desconocido
PROTECT: PReparing for Optimal Phase III/IV maTErnal Group B StreptococCal vaccine Trials in Africa (PROTECT)
MU JHU CARE LIMITED
participó en un
HORIZON EUROPE:
HORIZON-JU-GH-EDCTP3-2023-01
Two vaccines designed for pregnant women, to protect their unborn infant, are entering late phase development and will prevent infections fr...
2024-02-27 - 2027-02-28 | Financiado
2024-02-27 - 2027-02-28 | Financiado
SNIP-AFRICA: Severe neonatal infection adaptive platform trials in Africa
MU JHU CARE LIMITED
participó en un
HORIZON EUROPE:
HORIZON-JU-GH-EDCTP3-2022-01
SNIP-AFRICA aims to establish a clinical research network and architecture to implement adaptive platform trials in sub-Saharan Africa (SSA)...
2023-06-07 - 2028-06-30 | Financiado
2023-06-07 - 2028-06-30 | Financiado
* No se disponen de datos de la empresa actual.